HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phosphatidylinositol 3-kinase-dependent pathways oppose Fas-induced apoptosis and limit chloride secretion in human intestinal epithelial cells. Implications for inflammatory diarrheal states.

Abstract
The epithelial lining of the intestine serves as a barrier to lumenal bacteria and can be compromised by pathologic Fas-mediated epithelial apoptosis. Phosphatidylinositol (PI)3-kinase signaling has been described to limit apoptosis in other systems. We hypothesized that PI3-kinase-dependent pathways regulate Fas-mediated apoptosis and barrier function in intestiynal epithelial cells (IEC). IEC lines (HT-29 and T84) were exposed to agonist anti-Fas antibody in the presence or absence of chemical inhibitors of PI3-kinase (LY294002 and wortmannin). Apoptosis, barrier function, changes in short circuit current (DeltaI(sc)), and expression of adhesion molecules were assessed. Inhibition of PI3-kinase strongly sensitized IEC to Fas-mediated apoptosis. Expression of constitutively active Akt, a principal downstream effector of the PI3-kinase pathway, protected against Fas-mediated apoptosis to an extent that was comparable with expression of a genetic caspase inhibitor, p35. PI3-kinase inhibition sensitized to apoptosis by increasing and accelerating Fas-mediated caspase activation. Inhibition of PI3-kinase combined with cross-linking Fas was associated with increased permeability to molecules that were <400 Da but not those that were >3,000 Da. Inhibition of PI3-kinase resulted in chloride secretion that was augmented by cross-linking Fas. Confocal analyses revealed polymerization of actin and maintenance of epithelial cell adhesion molecule-mediated interactions in monolayers exposed to anti-Fas antibody in the context of PI3-kinase inhibition. PI3-kinase-dependent pathways, especially Akt, protect IEC against Fas-mediated apoptosis. Inhibition of PI3-kinase in the context of Fas signaling results in increased chloride secretion and barrier dysfunction. These findings suggest that agonists of PI3-kinase such as growth factors may have a dual effect on intestinal inflammation by protecting epithelial cells against immune-mediated apoptosis and limiting chloride secretory diarrhea.
AuthorsM T Abreu, E T Arnold, J Y Chow, K E Barrett
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 276 Issue 50 Pg. 47563-74 (Dec 14 2001) ISSN: 0021-9258 [Print] United States
PMID11551934 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Actins
  • Androstadienes
  • Chromones
  • Cross-Linking Reagents
  • Cytoskeletal Proteins
  • Desmoplakins
  • Enzyme Inhibitors
  • Membrane Proteins
  • Morpholines
  • Phosphoproteins
  • TJP1 protein, human
  • Tjp1 protein, mouse
  • Zonula Occludens-1 Protein
  • fas Receptor
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Chlorine
  • Phosphatidylinositol 3-Kinases
  • Caspases
  • Wortmannin
Topics
  • 3T3 Cells
  • Actins (metabolism)
  • Androstadienes (pharmacology)
  • Animals
  • Apoptosis
  • Blotting, Western
  • Caspases (metabolism)
  • Cell Adhesion
  • Cell Line
  • Cells, Cultured
  • Chlorine (metabolism)
  • Chromones (pharmacology)
  • Cross-Linking Reagents (pharmacology)
  • Cytoskeletal Proteins (biosynthesis)
  • Desmoplakins
  • Diarrhea (metabolism)
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors (pharmacology)
  • Epithelial Cells (metabolism)
  • Humans
  • Inflammation
  • Intestinal Mucosa (metabolism)
  • Membrane Proteins (biosynthesis)
  • Mice
  • Microscopy, Confocal
  • Microscopy, Fluorescence
  • Morpholines (pharmacology)
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphoproteins (biosynthesis)
  • Signal Transduction
  • Time Factors
  • Wortmannin
  • Zonula Occludens-1 Protein
  • fas Receptor (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: